Literature DB >> 37063

Can beta-blockers be used in diabetic patients?

H J Waal-Manning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 37063     DOI： 10.2165/00003495-197917030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  23 in total

1.  Blood sugar and beta-blockers.

Authors:  S P Linton; P H Scott; M J Kendall
Journal:  Br Med J       Date:  1976-10-09

2.  Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work.

Authors:  G Johnsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.

Authors:  S P Deacon; D Barnett
Journal:  Br Med J       Date:  1976-07-31

4.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

5.  Letter: Propranolol, hypoglycemia, and hypertensive crisis.

Authors:  R J McMurtry
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

6.  Propranolol-induced hypoglycaemia and myocardial infarction.

Authors:  R Wray; S B Sutcliffe
Journal:  Br Med J       Date:  1972-06-03

7.  Observations in man of hypoglycaemia during selective and non-selective beta-blockade.

Authors:  N M Davidson; R J Corrall; T R Shaw; E B French
Journal:  Scott Med J       Date:  1977-01       Impact factor: 0.729

8.  Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.

Authors:  L V Campbell; E W Kraegen; L Lazarus
Journal:  Br Med J       Date:  1977-12-10

9.  Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.

Authors:  S P Deacon; A Karunanayake; D Barnett
Journal:  Br Med J       Date:  1977-11-12

10.  Modification by propranolol of cardiovascular effects of induced hypoglycaemia.

Authors:  R H Lloyd-Mostyn; S Oram
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321
View more
  10 in total

1.  The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia.

Authors:  K J Schlüter; W H Aellig; K G Petersen; H C Rieband; A Wehrli; L Kerp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Hypoglycemia: a pitfall of insulin therapy.

Authors: 
Journal:  West J Med       Date:  1983-11

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 4.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

Review 5.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 6.  Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Authors:  G L Plosker; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 7.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

8.  Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.

Authors:  D Kerr; I A MacDonald; S R Heller; R B Tattersall
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

9.  Cardiovascular effects of eating, atenolol and their interaction: beta1-adrenergic modulation does not play a predominant role in the genesis of postprandial effects.

Authors:  C De Mey; D Enterling; I Meineke
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 10.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.